Vanda turns up the heat on FDA in bid to renew Appointments Clause challenge
A lawsuit over the generic drug approval process in place at the US Food and Drug Administration should move forward, Vanda Pharmaceuticals said today. In seeking to nudge a DC federal...To view the full article, register now.
Already a subscriber? Click here to view full article